Table 1.
Characteristic | Median (range) |
---|---|
| |
Age, years | 56 (28–75) |
| |
No. of patients (%) | |
| |
Gender | |
Female | 18 (51) |
Male | 17 (49) |
| |
Ethnicity | |
Hispanic or Latino | 3 ( 9) |
Non-Hispanic | 32 (91) |
| |
Race | |
Asian | 1 ( 3) |
Black or African American | 2 ( 6) |
More than one race | 1 ( 3) |
White | 30 (86) |
Other | 1 ( 3) |
| |
ECOG Performance Status | |
0 | 12 (34) |
1 | 21 (60) |
2 | 2 ( 6) |
| |
Primary Site | |
Parotid gland | 10 (29) |
Minor salivary gland | 12 (34) |
Other oro-naso-pharyngeal site | 8 (23) |
Trachea | 3 ( 9) |
Bartholin’s gland | 1 ( 3) |
Lacrimal | 1 ( 3) |
| |
Number of prior systemic regimens | |
0 | 18 (51) |
1 | 9 (26) |
2 | 4 (11) |
3 | 1 ( 3) |
4 or more | 3 ( 9) |
| |
Metastatic sites (multiple possible) | |
Lung | 32 (91) |
Liver | 15 (43) |
Bone | 16 (46) |
Kidney or spleen | 4 (11) |
Soft tissue | 11 (31) |